American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 2,Arthritis & Rheumatology

当前位置： X-MOL 学术 › Arthritis Rheumatol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 2
Arthritis & Rheumatology ( IF 13.3 ) Pub Date : 2021-06-10 , DOI: 10.1002/art.41772
Dawn M Wahezi ₁ , Mindy S Lo ₂ , Tamar B Rubinstein ₁ , Sarah Ringold ₃ , Stacy P Ardoin ₄ , Kevin J Downes ₅ , Karla B Jones ₄ , Ronald M Laxer ₆ , Rebecca Pellet Madan ₇ , Amy S Mudano ₈ , Amy S Turner ₉ , David R Karp ₁₀ , Jay J Mehta ₅

Affiliation

Children's Hospital at Montefiore and Albert Einstein College of Medicine, New York, New York, United States.
Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, United States.
Seattle Children's Hospital, Seattle, Washington, United States.
Nationwide Children's Hospital and Ohio State University, Columbus, Ohio, United States.
Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States.
University of Toronto and The Hospital for Sick Children, Toronto, Ontario, Canada.
New York University Grossman School of Medicine and Hassenfeld Children's Hospital, New York, New York, United States.
University of Alabama at Birmingham.
American College of Rheumatology, Atlanta, Georgia, United States.
University of Texas Southwestern Medical Center, Dallas.

To provide clinical guidance to rheumatology providers who treat children with pediatric rheumatic disease (PRD) in the context of the coronavirus disease 2019 (COVID-19) pandemic.

中文翻译：